NRTpregnancyNHSNational Health Service
…1) usual care (UC) or (2) UC plus an intervention combining (1) NRT for preloading, (2) counselling to continue NRT during brief sm…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 721–780 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Dapsone5Diclofenac5Epirubicin5FibroScan5Hyperbaric bupivacaine5ICB5ICS/LABA5IFNγ5IL-185SARS-CoV-25donanemab5immunomodulators5low-dose aspirin5tapentadol5thiazolidinediones56-mercaptopurine5High-dose steroids5JAK inhibitors5Letrozole5Mercaptopurine5Steroid5Trastuzumab Emtansine5Vitamin B125antiseizure medication5candesartan5ganciclovir5immune checkpoint inhibitor5non-steroidal anti-inflammatory drug5normal saline5nortriptyline5supplemental oxygen5ASMs5Atracurium5Bacillus Calmette-Guérin5Bendamustine5High-dose intravenous methylprednisolone5SF-365Selective Serotonin Reuptake Inhibitors5acetic acid5contraceptives5delpar5intravenous ceftriaxone5liposomal amphotericin B5prescription opioids5topical corticosteroids5venlafaxine5DPP4i4ELA4Estrogen4Rilvegostomig4HM163904Alectinib4Penumbra4RP14LEvoSimendan4Nipocalimab4Dinutuximab4SEL4BLM4IL-17i4
Articles mentioning drugs
10,506 articles · page 301 of 876LoberamisalAISacute ischaemic strokeNCT06429384ChiCTR2400081662
…y, and 90.2% (55/61) in the placebo group (p=0.260).Conclusions Loberamisal injection was well tolerated in patients with AIS within 48 hou…
Prednisoloneprednisolone-associatedhyperglycemiaACTRN12618001211257
…Introduction Prednisolone is widely prescribed to hospitalized patients for a range of co…
OKT3Cytokine release syndromeTransCure bioServicesCRSimmune checkpoint inhibitorsT cell engagers
…humanized mouse models exhibited hallmark symptoms of CRS after OKT3 injection, including hyperventilation, respiratory distress, ed…
nivolumabpembrolizumabatezolizumabNSCLCUniversity of Houston Institutional Review Board
…hemotherapy (HR=2.35; 95% CI:1.39–3.96) or pembrolizumab versus nivolumab (HR=2.46; 95%CI:1.13–5.36) ( figure 1) also conferred a higher …
pembrolizumabdurvalumabnivolumabatezolizumabTNBCtriple-negative breast cancerTriNetX
… TNBC (ER-/PR-/HER2-) who received at least one dose of an ICI (pembrolizumab, atezolizumab, nivolumab, or durvalumab) between 2014 and 2025.…
88.6%
ICIDana-Farber Cancer InstituteDartmouth Cancer CenterRhode Island HospitalHNSCCR/M HNSCC
…Background Immune checkpoint inhibitors (ICI) are the current standard of care for patients with recurrent/m…
QHT025TMZNP1867PD-1 blockade monotherapyCRC
… for assessing MSI activity. Using this approach, we discovered QHT025: a small-molecule modulator that induces MSI-H and functional M…
NOUS-209NOUS-209-mediatedLynch syndromecolorectal cancersurothelial cancers
…thereby offering promising targets for precision immunotherapy. NOUS-209 is a genetic vaccine encoding 209 neoantigens shared across spo…
MCT4iVB124MCT4 inhibitormelanomagastric cancerPD-1 blockade
…aluated. Changes within the TIME of multiple mouse models after MCT4i and/or PD-1 blockade was characterized by multispectral flow cy…
95.2%
SABRACacid ceramidase inhibitorsoligodendrogliomaNational Cancer Institute
…vels and its derivatives from the salvage pathway. In addition, SABRAC demonstrated to increase MHC class I (MHC-I) surface levels in …
COMP-015solid tumors
…osine-rich TMEs.Methods A potent and selective A2aR antagonist, COMP-015 was evaluated for its ability to block A2aR signaling under hig…